The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

被引:202
作者
Lazarus, Jeffrey V. [1 ]
Safreed-Harmon, Kelly [1 ]
Thursz, Mark R. [2 ]
Dillon, John F. [3 ]
El-Sayed, Manal H. [4 ]
Elsharkawy, Ahmed M. [5 ]
Hatzakis, Angelos [6 ]
Jadoul, Michel [7 ]
Prestileo, Tullio [8 ,9 ]
Razavi, Homie [10 ]
Rockstroh, Juergen K. [11 ]
Wiktor, Stefan Z. [12 ,13 ]
Colombo, Massimo [14 ]
机构
[1] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Calle Rosello 132,4th Floor, ES-08036 Barcelona, Spain
[2] Imperial Coll, Dept Surg & Canc, London, England
[3] Univ Dundee, Sch Med, Div Mol & Clin Med, Dundee, Scotland
[4] Ain Shams Univ, Dept Pediat, Cairo, Egypt
[5] Univ Hosp Birmingham, Mindelsohn Way, Birmingham, W Midlands, England
[6] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[7] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, Brussels, Belgium
[8] Civicobenfratelli Hosp, Infect Dis Unit, Palermo, Italy
[9] Civicobenfratelli Hosp, ARNAS, Ctr Migrat & Hlth, Palermo, Italy
[10] Ctr Dis Anal Fdn, Lafayette, CO USA
[11] Univ Bonn, Dept Med 1, Bonn, Germany
[12] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA
[13] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA
[14] Humanitas Hosp, Clin & Res Ctr, Dept Med, Rozzano, Italy
关键词
health policy; hepatitis C; micro-elimination; health systems; models of care; VIRUS-INFECTION; INJECT DRUGS; PUBLIC-HEALTH; PREVENTION; PEOPLE; HCV; TRANSMISSION; BIRTH; CARE; MANAGEMENT;
D O I
10.1055/s-0038-1666841
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives that tailor interventions to the needs of these populations. Micro-elimination is less daunting, less complex, and less costly than full-scale, country-level initiatives to eliminate HCV, and it can build momentum by producing small victories that inspire more ambitious efforts. The micro-elimination approach encourages stakeholders who are most knowledgeable about specific populations to engage with each other and also promotes the uptake of new models of care. Examples of micro-elimination target populations include medical patients, people who inject drugs, migrants, and prisoners, although candidate populations can be expected to vary greatly in different countries and subnational areas.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 110 条
[61]   Historical epidemiology of hepatitis C virus in select countries-volume 4 [J].
Maaroufi, A. ;
Vince, A. ;
Himatt, S. M. ;
Mohamed, R. ;
Fung, J. ;
Opare-Sem, O. ;
Workneh, A. ;
Njouom, R. ;
Al Ghazzawi, I. ;
Abdulla, M. ;
Kaliaskarova, K. S. ;
Owusu-Ofori, S. ;
Abdelmageed, M. K. ;
Adda, D. ;
Akin, O. ;
Al Baqali, A. ;
Al Dweik, N. ;
Al Ejji, K. ;
Al Kaabi, S. ;
Al Naamani, K. ;
Al Qamish, J. ;
Al Sadadi, M. ;
Al Salman, J. ;
AlBadri, M. ;
Al-Busafi, S. A. ;
Al-Romaihi, H. E. ;
Ampofo, W. ;
Antonov, K. ;
Anyaike, C. ;
Arome, F. ;
Bane, A. ;
Blach, S. ;
Borodo, M. M. ;
Brandon, S. M. ;
Bright, B. ;
Butt, M. T. ;
Cardenas, I. ;
Chan, H. L. Y. ;
Chen, C. J. ;
Chen, D. S. ;
Chen, P. J. ;
Chien, R. N. ;
Chuang, W. L. ;
Cuellar, D. ;
Derbala, M. ;
Elbardiny, A. A. ;
Estes, C. ;
Farag, E. ;
Gamkrelidze, I. ;
Garcia, V. .
JOURNAL OF VIRAL HEPATITIS, 2017, 24 :8-24
[62]   Feasibility of Treating Hepatitis C in a Transient Jail Population [J].
MacDonald, Ross ;
Akiyama, Matthew J. ;
Kopolowl, Aimee ;
Rosner, Zachary ;
McGahee, Wendy ;
Joseph, Rodrigue ;
Jaffer, Mohamed ;
Venters, Homer .
OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (03)
[63]   Understanding barriers to health care: A review of disparities in health care services among indigenous populations [J].
Marrone, Sonia .
INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2007, 66 (03) :188-198
[64]   Is Increased Hepatitis C Virus Case-Finding Combined With Current or 8-Week to 12-Week Direct-Acting Antiviral Therapy Cost-Effective in UK Prisons? A Prevention Benefit Analysis [J].
Martin, Natasha K. ;
Vickerman, Peter ;
Brew, Iain F. ;
Williamson, Joan ;
Miners, Alec ;
Irving, William L. ;
Saksena, Sushma ;
Hutchinson, Sharon J. ;
Mandal, Sema ;
O'Moore, Eamonn ;
Hickman, Matthew .
HEPATOLOGY, 2016, 63 (06) :1796-1808
[65]   A pilot study to expand treatment of chronic hepatitis C in resource-limited settings [J].
Mathur, Poonam ;
Comstock, Emily ;
McSweegan, Edward ;
Mercer, Natalia ;
Kumar, Nongthombam Suraj ;
Kottilil, Shyamasundaran .
ANTIVIRAL RESEARCH, 2017, 146 :184-190
[66]  
Matii M, 2018, EASL INT LIV C APR 1
[67]  
Mera J, 2016, MMWR-MORBID MORTAL W, V65, P461, DOI 10.15585/mmwr.mm6518a2
[68]  
Ministry of Labour Health and Social Affairs, 2016, STRAT PLAN EL HEP C
[69]   Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction [J].
Moini, Maryam ;
Ziyaeyan, Mazyar ;
Aghaei, Shapoor ;
Sagheb, Mohammad Mahdi ;
Taghavi, Seyed Alireza ;
Moeini, Mahsa ;
Jamalidous, Marzieh ;
Hamidpour, Laleh .
HEPATITIS MONTHLY, 2013, 13 (06)
[70]   Economic evaluation of HCV testing approaches in low and middle income countries [J].
Morgan, Jake R. ;
Servidone, Maria ;
Easterbrook, Philippa ;
Linas, Benjamin P. .
BMC INFECTIOUS DISEASES, 2017, 17